The understudied relationship between muscle mass and nonalcoholic fatty liver disease is assessed, including expert opinions the topic.
Investigators assessed the safety and efficacy of PXL770 in reducing liver fat content in patients with nonalcoholic fatty liver disease.
Researchers examined the effect of a green-Mediterranean diet enriched with plant-based polyphenols and less red and processed meat on reduction of liver fat.
The pooled prevalence of primary sclerosing cholangitis (PSC) is 2.16 percent in patients with inflammatory bowel disease.
Investigators assessed the incidence of major adverse cardiovascular events in patients with histologically-confirmed nonalcoholic fatty liver disease.
Investigators assessed outcomes in patients with cirrhosis following receipt of the Pfizer or Moderna COVID-19 vaccine.
In 77 percent of patients, the enhanced liver fibrosis score category remained stable; however, at one year, 18 percent experienced worsening of fibrosis, with no substantial difference between the groups.
Rivoceranib is an orally administered, small molecule inhibitor of vascular endothelial growth factor receptor 2 (VEGFR-2).
An overview of research indicating the association between rheumatic diseases and the liver, and the management of patients with rheumatic disease with liver involvement.
Investigators assessed the effects of dietary artichoke supplementation on levels of liver enzymes.
Investigators assessed the long-term outcomes of patients with cirrhosis and ascites switched from treatment with propranolol to carvedilol.
Investigators compared the safety and efficacy of different treatments for patients with portal hypertension and cirrhosis.
Elevated serum iron and transferrin saturation levels are significantly associated with an increased risk for developing liver cancer in patients with NAFLD.
Nonoverweight patients with nonalcoholic fatty liver disease cirrhosis who are on the transplant wait list have worse pre- and post-liver transplant outcomes.
Almost one in five patients with cirrhosis receive opioid prescriptions during outpatient visits.
Investigators aimed to determine whether availability of a living donor could overcome the disparity in access to liver transplant among women.
The designation is based on results from a phase 1 study that evaluated TT-00420 at different dose levels in 9 CCA patients.
Investigators assessed how certain factors influence the prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease.
All U.S. adults younger than 60 years should be vaccinated against hepatitis B, the Advisory Committee on Immunization Practices recommended.
Researchers investigated survival outcomes for patients with alcohol-associated liver disease undergoing early vs standard liver transplant.